FEED ENvue Medical, Inc.
Price Chart
Executive Summary
ENvue Medical announced a peer-reviewed study published in Critical Care Nurse showing that its ENvue Navigation Platform reduced ventilator-associated pneumonia (VAP) by 67%, saved over 350 nursing hours, and cut repeat imaging by 20% at Inova Health System. The study supports the company's commercialization efforts by providing clinical evidence for hospital adoption, but the press release contains no financial results or guidance.
Actionable Insight
The study provides strong clinical evidence for hospital adoption, which could accelerate ENvue's commercial footprint. However, the company has not disclosed any revenue or guidance — the stock is a micro-cap with a history of negative post-report returns. Monitor for future hospital contract announcements or revenue disclosures to validate the commercialization thesis.
Key Facts
- Independent peer-reviewed study published in Critical Care Nurse (official journal of AACN) on ENvue Navigation Platform at Inova Health System (5 hospitals).
- VAP cases reduced by 67%; zero accidental lung insertions across 531 consecutive placements in year one.
- Over 350 nursing hours saved in year one; 20% fewer X-rays needed; 20% reduction in hospital-acquired aspiration pneumonia.
- Estimated over $1.5 million in hospital costs avoided in year one based on AHRQ benchmarks.
- No financial results, revenue, EPS, or guidance were provided in the press release.
- Market cap is $6M; stock is micro-cap with high volatility (historical T+5 average call P&L -8.52%).
Financial Impact
Over $1.5 million in hospital cost savings per year at Inova Health System (5 hospitals); no company revenue or financial data disclosed.
Risk Factors
- No revenue or financial data provided — commercialization impact is speculative.
- Micro-cap stock ($6M market cap) with high volatility and negative historical post-report returns.
- Forward-looking statements are aspirational; actual hospital adoption may lag.
- Competition from other feeding tube placement technologies.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3306023 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
9d ago
|
Press Release
| $0.8600 $0.8500 | ▼ −1.16% | ▼ −1.56% | $0.8290 (−3.60%) |
|
May 29, 2026
15d ago
|
EFFECT
| $0.9020 $0.9040 | ▼ −0.22% | ▲ +0.04% | $0.8290 (+8.09%) |
|
May 18, 2026
25d ago
|
S-3
| $0.9300 $0.9310 | ▼ −0.11% | ▲ +0.93% | $0.8290 (+10.86%) |
|
May 12, 2026
4w ago
|
Press Release
| $1.24 $1.16 | ▼ −6.45% | ▼ −7.03% | $0.8290 (−33.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access